KAVI Institute of Clinical Research

Kenya AIDS Vaccine Initiative (KAVI) was established in 1998 as a research unit within the Department of Medical Microbiology, with an initial mission to conduct basic research in epidemiology of HIV and to carryout HIV/AIDs

vaccine trials.

Over the years, KAVI experienced tremendous growth as a result of sustained funding, hence the development of human capacity, infrastructure and community mobilization catchment  areas. By 2013, KAVI as a research unit had successfully undertaken eight HIV vaccine trials,  two drug trials, thirteen epidemiological and basic research projects in addition to pioneering  the development of mucosal sampling and standardization of mucosal immune assays. KAVI  has also greatly assisted in the development of human capacity within the East African region  by training various Institutional Ethics boards and clinical research personnel on research ethics, Good Clinical Practice (GCP) and Good Clinical and Laboratory Practice (GCLP). KAVI  has also been involved in the strengthening of Laboratory management systems of various health institutions to prepare the institutions for accreditation.